BE843195A - Nouvel agent antidiabetique et derives d'isoxazole - Google Patents

Nouvel agent antidiabetique et derives d'isoxazole

Info

Publication number
BE843195A
BE843195A BE168133A BE168133A BE843195A BE 843195 A BE843195 A BE 843195A BE 168133 A BE168133 A BE 168133A BE 168133 A BE168133 A BE 168133A BE 843195 A BE843195 A BE 843195A
Authority
BE
Belgium
Prior art keywords
isoxazole derivatives
new antidiabetic
antidiabetic
new
isoxazole
Prior art date
Application number
BE168133A
Other languages
English (en)
French (fr)
Inventor
T Irikura
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE843195A publication Critical patent/BE843195A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BE168133A 1975-06-21 1976-06-21 Nouvel agent antidiabetique et derives d'isoxazole BE843195A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP50076176A JPS52264A (en) 1975-06-21 1975-06-21 Process for preparing novel isoxazole derivatives

Publications (1)

Publication Number Publication Date
BE843195A true BE843195A (fr) 1976-10-18

Family

ID=13597782

Family Applications (1)

Application Number Title Priority Date Filing Date
BE168133A BE843195A (fr) 1975-06-21 1976-06-21 Nouvel agent antidiabetique et derives d'isoxazole

Country Status (13)

Country Link
US (1) US4026902A (OSRAM)
JP (1) JPS52264A (OSRAM)
AR (1) AR209492A1 (OSRAM)
AU (1) AU497558B2 (OSRAM)
BE (1) BE843195A (OSRAM)
CA (1) CA1050996A (OSRAM)
DE (1) DE2627696A1 (OSRAM)
ES (1) ES449068A1 (OSRAM)
FR (1) FR2315923A1 (OSRAM)
GB (1) GB1529403A (OSRAM)
SE (1) SE428688B (OSRAM)
SU (1) SU584774A3 (OSRAM)
ZA (1) ZA763356B (OSRAM)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196046A (en) * 1984-07-26 1993-03-23 Rohm And Haas Company N-acetonyl-substituted-amides
US4863940A (en) * 1984-07-26 1989-09-05 Rohm And Haas N-acetonyl-substituted amides and phytopathogenic fungicidal use thereof
US4717064A (en) * 1986-08-15 1988-01-05 Unisys Corporation Wave solder finger shield apparatus
US5258397A (en) * 1988-11-30 1993-11-02 Novapharme 3-Isoxazoyl derivatives endowed with anticonvulsant activity, procedure for their preparation and their pharmaceutical compositions
FR2662692B1 (fr) * 1990-05-30 1995-04-28 Novapharme Derives heterocycliques doues d'activite anticonvulsivante, procede de preparation et composition pharmaceutique.
FR2639636B1 (fr) * 1988-11-30 1994-03-04 Novapharme Nouveaux composes heterocycliques a activite anticonvulsivante, procede de preparation et compositions therapeutiques les contenant
US4930204A (en) * 1989-02-01 1990-06-05 A. O. Smith Corporation Method of forming composite tubular structure

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2073284B1 (OSRAM) * 1969-12-23 1973-07-13 Ferlux

Also Published As

Publication number Publication date
FR2315923A1 (fr) 1977-01-28
DE2627696A1 (de) 1977-01-13
GB1529403A (en) 1978-10-18
JPS5314067B2 (OSRAM) 1978-05-15
FR2315923B1 (OSRAM) 1979-09-21
AU1459376A (en) 1977-12-08
AU497558B2 (en) 1978-12-14
SU584774A3 (ru) 1977-12-15
ZA763356B (en) 1977-05-25
AR209492A1 (es) 1977-04-29
SE428688B (sv) 1983-07-18
JPS52264A (en) 1977-01-05
US4026902A (en) 1977-05-31
SE7607038L (sv) 1976-12-22
CA1050996A (en) 1979-03-20
ES449068A1 (es) 1977-07-16

Similar Documents

Publication Publication Date Title
SE432928B (sv) Forfarande for framstellning 4,5,6-trinor-3,7-inter-m-fenylen-pge, och vissa derivat derav
HU175109B (hu) Sposob poluchenija novykh benzgidril-sul'finilovykh proizvodnykh
NL7613450A (nl) 3.4-dihydrochinazolinederivaten en werkwijzen ter bereiding ervan.
FR2304410A1 (fr) Tourniquet d'arrosage
BE860782A (fr) Derives d'anthracycline
BE876238A (fr) Derives d'isopropylbenzene et leur preparation
FR2297046A1 (fr) Derives d'adamantane et leur application
FR2302812A1 (fr) Machine d'oxycoupage
BE843195A (fr) Nouvel agent antidiabetique et derives d'isoxazole
FR2332747A1 (fr) Derives d'a-aminocetones
FR2318863A1 (fr) Bestatine et ses derives
SE426166B (sv) Fortjockad och tverbunden vattenhaltig skumsprengemneskomposition
FR2322604A1 (fr) Derives 3-triazolylthio d'ureido-7a-methoxy-ou demethoxycephalosporines
SE7609908L (sv) 1,5-dihydro-2h-1,4-bensodiazepin-2-on-derivat och framstellning derav
BE850472A (fr) Derives d'imidazothiazole et theiazolopyrimidine antiinflammatoires
FR2301390A1 (fr) Classeur-relieur d'archives
BE868590A (fr) Derives alpha-acetyleniques et alpha-vinyliques d'amino-acides
SE7812832L (sv) 2'-n-acyl och alkyl-6'-n-alkyl- och 6',6'-di-n-alkyl-derivat av fortimiciner a och b
FR2321470A1 (fr) 1,1-dichloro-4-methyl-3-hydroxy-pentene-(1) et sa preparation
BE855393A (fr) Composition therapeutique a base de derives thiazoliques et sa preparation
FR2336398A1 (fr) Le 4-methylimidazole-5-carboxylate d'isopropyle et sa preparation
BE843962A (fr) Preparation d'un oxazole
ZA762888B (en) 3,5-bisoxygenated 2-(omega-halo-3-oxygenated-1-alkenyl)-cyclopentane-1-heptanoic acids and derivatives thereof
HU175490B (hu) Ustrojstvo vybora naprjazhenija dlja grupirovki otopitel'nykh soprotivlenij u zheleznodorozhnykh vagonov mezhdunarodnogo soobhhenija
BE862444A (fr) Derives d'isoquinoleine-acetamide

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: KYORIN PHARMACEUTICAL CO. LTD

Effective date: 19910630